GlaxoSmithKline: all 4,196 studies
Page 30 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Korean Practice Patterns for Screening PCA(Prostate Cancer)CompletedNCT01371513
- GSK1120212 Food-effect StudyCompletedNCT01371487Phase 1
- Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)CompletedNCT01371474
- Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)CompletedNCT01371461
- Special Drug Use Investigation for PAXIL Tablet (Long-term)CompletedNCT01371448
- Drug Use Investigation for PAXIL TabletCompletedNCT01371435
- CV Events in Emetogenic ChemotherapyCompletedNCT01366599
- GSK1521498 Alcohol Interaction StudyCompletedNCT01366573Phase 1
- Effect of GSK962040 on Oesophageal FunctionCompletedNCT01366560Phase 1
- Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination TabletsCompletedNCT01366547Phase 1
- A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of FoodTerminatedNCT01366508Phase 1
- To Evaluate the Incidence of Acute Otitis Media in Children in Five East European CountriesCompletedNCT01365390
- Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive PatientsCompletedNCT01362283
- A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719CompletedNCT01362257Phase 1
- Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in ChinaCompletedNCT01357902Phase 1
- Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 DiabeticsCompletedNCT01357876Phase 1
- Role of Early Versus Late Switch to Lapatinib-CapecitabineTerminatedNCT01357863
- Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review StudyCompletedNCT01353768
- Lamivudine and Adefovir Dipivoxil Fixed Dose CombinationCompletedNCT01353742Phase 1
- A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy VolunteersCompletedNCT01353729Phase 1
- Dolutegravir Renal Impairment StudyCompletedNCT01353716Phase 1
- Indirect Comparison Topotecan Cervical CarcinomaCompletedNCT01345279
- Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung MorphometryCompletedNCT01345266Phase 1
- A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic DiseasesCompletedNCT01340911Phase 1
- A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01340846Phase 1
- Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01340833Phase 1
- Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in BelgiumCompletedNCT01339221
- Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy SettingTerminatedNCT01337323
- Economic Analyses of the REDUCE TrialCompletedNCT01337258
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese SubjectsCompletedNCT01332565Phase 1
- A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C SubjectsTerminatedNCT01332552Phase 1
- An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in ItalyCompletedNCT01332539
- An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.CompletedNCT01332513Phase 1
- JCP Study of Investigation of Patient Background CharacteristicsCompletedNCT01332474
- Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical TrialsCompletedNCT01332448
- Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric)CompletedNCT01332422
- Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)CompletedNCT01332409
- Special Drug Use Investigation for AMERGE® Tablet (Long-term)CompletedNCT01332383
- Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs RosiglitazoneCompletedNCT01332370
- Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled CorticosteroidsCompletedNCT01332344
- EuroSIDA As An External Comparator To MOTIVATE TrialsCompletedNCT01329783
- Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal MelanomaWithdrawnNCT01328106Phase 2
- Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New ZealandCompletedNCT01328028
- GSK BHR Study (Sont - Second Study)CompletedNCT01324362Phase 4
- Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid TumorsCompletedNCT01324258Phase 1
- SAP Depleter Dose Escalation Study in Healthy VolunteersCompletedNCT01323985Phase 1
- A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01319019Phase 2
- Relative Bioavailability Study for GSK1278863ACompletedNCT01319006Phase 1
- A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915ACompletedNCT01318980Phase 1
- Coreg and HSRs-Updated AnalysisCompletedNCT01316952
- A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.CompletedNCT01299597Phase 1
- Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy SubjectsCompletedNCT01299558Phase 1
- Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)CompletedNCT01294605Phase 4
- FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese VolunteersCompletedNCT01294566Phase 1
- A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United KingdomTerminatedNCT01292213
- Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in CanadaTerminatedNCT01290393
- Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast CancerCompletedNCT01290354Phase 1
- Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsCompletedNCT01290211Phase 1
- GSK2190915 Pediatric StudyWithdrawnNCT01286844Phase 2
- A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444.CompletedNCT01286831Phase 1
- A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.WithdrawnNCT01283100Phase 1
- Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®CompletedNCT01277705Phase 3
- A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.CompletedNCT01277692Phase 1
- Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac FailureCompletedNCT01277679Phase 1
- A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult SubjectsWithdrawnNCT01273103Phase 1
- An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult SubjectsCompletedNCT01267968Phase 1
- A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy VolunteersCompletedNCT01267071Phase 1
- Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy AdultsCompletedNCT01267058Phase 3
- Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years OldCompletedNCT01267006Phase 1
- A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.CompletedNCT01266980Phase 1
- An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian CancerCompletedNCT01266954Phase 1
- A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.CompletedNCT01266941Phase 1
- An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01262963Phase 1
- Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis VaccineCompletedNCT01262924Phase 3
- Effect of SRT2379 on Endotoxin-Induced InflammationCompletedNCT01262911Phase 1
- A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult SubjectsCompletedNCT01262885Phase 1
- A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy VolunteersCompletedNCT01258530Phase 1
- A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.CompletedNCT01254071Phase 1
- Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPDCompletedNCT01254032
- Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in RomaniaCompletedNCT01253967
- Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in KoreaCompletedNCT01248988
- Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for AsthmaCompletedNCT01248975Phase 2
- Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With LapatinibCompletedNCT01248897
- Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.TerminatedNCT01248858Phase 1
- A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)CompletedNCT01245426Phase 2
- A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)WithdrawnNCT01244009Phase 2
- Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT01236638Phase 2
- Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in AustraliaCompletedNCT01236066
- Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years OldCompletedNCT01236040Phase 1
- Indirect Comparison Between Eltrombopag & RomiplostimCompletedNCT01236014
- Meta-analysis - EltrombopagCompletedNCT01235988
- An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive TumorCompletedNCT01231568Phase 1
- Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female VolunteersCompletedNCT01231542Phase 1
- GSK1349572 Hepatic Impairment StudyCompletedNCT01231529Phase 1
- Acute Osteoarthritis Experimental Model Study.CompletedNCT01231490Phase 2
- MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)TerminatedNCT01227941Phase 1
- Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate TreatmentCompletedNCT01227369
- Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical CancerCompletedNCT01221987
- A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy SubjectsCompletedNCT01214993Phase 1
- Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an InhalerCompletedNCT01213849Phase 1